- Conditions
- Infertility (IVF Patients), Infertility Treatment, Post-op Pain, Fresh Embryo Transfer, Oocyte Retrieval and Post Operative Pain Control
- Interventions
- Ketorolac 30 mg IV
- Drug
- Lead sponsor
- Jessica D. Kresowik
- Other
- Eligibility
- 18 Years to 37 Years · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
Source: ClinicalTrials.gov public record
Updated Dec 14, 2025 · Synced May 22, 2026, 2:27 AM EDT